Chemokines and chemokine receptors in model neurological pathologies: molecular and immunocytochemical approaches.
Ransohoff
R M
RM
Department of Neurosciences, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Ohio 44195, USA.
Tani
M
M
Glabinski
A R
AR
Chernosky
A
A
Krivacic
K
K
Peterson
J W
JW
Chien
H F
HF
Trapp
B D
BD
D000818:Animals; D015152:Blotting, Northern; D018925:Chemokines / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology; D005455:Fluorescent Antibody Technique; D005786:Gene Expression Regulation; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008274:Magnesium / Q000494:pharmacology; D009420:Nervous System / Q000276:immunology*; D009422:Nervous System Diseases / Q000276:immunology* / Q000378:metabolism; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis; D019707:Receptors, Chemokine / Q000032:analysis* / Q000276:immunology; D012260:Ribonucleases / Q000378:metabolism; D012377:Rodentia
D018925:Chemokines; D012333:RNA, Messenger; D019707:Receptors, Chemokine; D012260:Ribonucleases; D008274:Magnesium